Reducing Obesity Using Social Ties (ROBUST): Randomized Control Trial

Status: Recruiting
Location: See location...
Intervention Type: Behavioral, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This trial aims to test the feasibility and acceptability of addressing interpersonal barriers to weight-related behavior change. Specifically, the study will test if, by including up to two friends, family members, or co-workers in a lifestyle intervention for weight loss, the person enrolled in the study loses more weight than someone whose friends, family members, or co-workers were not invited to participate.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Index Participant:

‣ Black race or Hispanic ethnicity

⁃ Male or Female 18 years of age or older

⁃ Calculated BMI \> 30kg/m2 from objectively measured height and weight by study staff

⁃ Access \& willingness to use program food intake app via home computer or a smartphone

⁃ Ability to identify at least one adult social network member who will participate in the study

• Social Network Member:

‣ Male or Female 18 years of age or older

⁃ Access to the internet or a smartphone

Locations
United States
New York
Weill Cornell Medicine
RECRUITING
New York
Contact Information
Primary
Rosio Ramos, BS
ror2023@med.cornell.edu
646-962-5037
Backup
Anika Lewis, MS
ale4008@med.cornell.edu
Time Frame
Start Date: 2024-04-05
Estimated Completion Date: 2026-03-01
Participants
Target number of participants: 264
Treatments
Experimental: Social Network Intervention
Participants will complete 3 communication skills sessions with their social network members during weeks 3, 5, and 15.
Placebo_comparator: Individual Lifestyle Intervention
Participants will complete standard diabetes prevention program (DPP) based health coaching sessions during weeks 3, 5, and 15.
Other: Social Network Member
Social Network Members will complete 3 communication skills sessions with the social network intervention participant during weeks 3, 5, and 15.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: Weill Medical College of Cornell University

This content was sourced from clinicaltrials.gov